Today, she is the third-generation promoter face at Cipla, an 81-year-old legacy drug company known globally for offering reverse engineered life saving drugs at a fraction of the cost of patented drugs. Her younger brother, Kamil Hamied worked with Cipla for about eight years and rose to the position of Chief Strategy Officer, but decided to pursue his own business interests and left the company in 2015, when he was expected to succeed the senior Hamieds. As executive vice chairman since last September, Samina heads the company's board, responsible for handling governance issues and chalking out strategic priorities through global partnerships, corporate branding and public advocacy. "The biggest challenge is to create a new and more future ready Cipla. We have put together an enviable management team and are building a strong organisation, strongly anchored on our OneCipla Credo, that we have just articulated.